NEW YORK (GenomeWeb News) – Genetic Technologies will distribute Rosetta Genomics' cancer diagnostic tests in Australia, New Zealand, and Singapore, under an exclusive agreement announced by Rosetta Genomics today.

GTG, a Melbourne-based genetic testing lab, will market the company's microRNA-based miRview tests in the three countries, Rosetta Genomics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.